» Authors » Jinlin Pan

Jinlin Pan

Explore the profile of Jinlin Pan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 4
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao Y, Zhou X, Hong L, Yao J, Pan J, Shafi S, et al.
Int Immunopharmacol . 2024 Dec; 147():113915. PMID: 39740503
Background: Glioblastoma (GBM) is the most aggressive tumor in the central nervous system. Tumor-associated macrophage (TAMs) represent a major immune cell population in tumor microenvironment (TME) and exert immunosuppressive effects...
2.
Han Y, Zhou Y, Pan J, Sun M, Yang J
Expert Rev Mol Med . 2024 Dec; 27():e4. PMID: 39628046
Glycosylation modifications of proteins and glycan hydrolysis are critical for protein function in biological processes. Aberrations in glycosylation enzymes are linked to lysosomal storage disorders (LSDs), immune interactions, congenital disorders...
3.
Zhao R, Yang J, Zhai Y, Zhang H, Zhou Y, Hong L, et al.
Nat Immunol . 2024 Aug; 25(9):1565-1579. PMID: 39103576
Nucleophosmin 1 (NPM1) is commonly mutated in myelodysplastic syndrome (MDS) and acute myeloid leukemia. Concurrent inflammatory bowel diseases (IBD) and MDS are common, indicating a close relationship between IBD and...
4.
Han Y, Hu J, Pan J, Song X, Zhou Y, Zhang J, et al.
Int Immunopharmacol . 2024 May; 135:112283. PMID: 38772299
Toll-like receptors (TLRs) play a crucial role in mediating immune responses by recognizing pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs), as well as facilitating apoptotic cell (ACs) clearance...
5.
Sun L, Ouyang N, Shafi S, Zhao R, Pan J, Hong L, et al.
Technol Cancer Res Treat . 2023 Mar; 22:15330338231161141. PMID: 36960492
Nuclear respiratory factor 1 (NRF1) is an important regulator involved in mitochondrial biogenesis and energy metabolism. However, the specific mechanism of NRF1 in anoikis and epithelial-mesenchymal transition (EMT) remains unclear....
6.
Pan J, Zhao R, Dong C, Yang J, Zhang R, Sun M, et al.
BMC Neurosci . 2023 Feb; 24(1):10. PMID: 36721107
Background: Glioblastoma (GBM) is the most common malignant intracranial tumor with a low survival rate. However, only few drugs responsible for GBM therpies, hence new drug development for it is...
7.
Zhao R, Zhou Y, Zhang H, Pan J, Yang F, Zhang R, et al.
J Clin Med . 2022 Jul; 11(13). PMID: 35806945
Glioblastoma multiforme (GBM) is an aggressive brain tumor with high risks of recurrence and mortality. Chemoradiotherapy resistance has been considered a major factor contributing to the extremely poor prognosis of...
8.
Zhao R, Sa X, Ouyang N, Zhang H, Yang J, Pan J, et al.
Front Genet . 2021 Nov; 12:723725. PMID: 34759954
Numerous studies have identified various prognostic long non-coding RNAs (LncRNAs) in a specific cancer type, but a comprehensive pan-cancer analysis for prediction of LncRNAs that may serve as prognostic biomarkers...